Jochen Schmitz - Siemens Healthineers CFO, Member of the Managing Board
SEMHF Stock | USD 53.00 1.37 2.65% |
CFO
Dr. Jochen Schmitz, Ph.D., was Chief Financial Officer and Member of the Managing Board of Siemens Healthineers AG since December 2017. He joined Siemens in 1996 after the completion of his studies in Business Administration and Economics at the University of Augsburg. He also holds a Ph.D. in the same field. After various positions with increasing responsibility in Corporationrationrate Finance in Germany he joined Siemens Healthcare in 2004, holding several executive finance positions in the Healthcare business in the United States and Germany. Among others he was Chief Financial Officer of the Diagnostics Division in the United States and Chief Financial Officer of the Imaging Therapy Systems Division in Germany until 2011. Afterwards, he had served for six years as Corporationrationrate Vice President Controller of Siemens AG until he finally came back to Siemens Healthineers. since 2017.
Age | 57 |
Tenure | 7 years |
Phone | 49 9131 84 3385 |
Web | https://www.siemens-healthineers.com |
Siemens Healthineers Management Efficiency
The company has return on total asset (ROA) of 0.0383 % which means that it generated a profit of $0.0383 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1129 %, meaning that it generated $0.1129 on every $100 dollars invested by stockholders. Siemens Healthineers' management efficiency ratios could be used to measure how well Siemens Healthineers manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Found 9 records | CFO Age | ||
Douglas Rice | Orthofix Medical | 58 | |
Todd CPA | CONMED | 55 | |
Diron Smith | Integer Holdings Corp | 50 | |
Lance CPA | Artivion | 52 | |
Stephen Griffin | Anika Therapeutics | 38 | |
Chadi Chahine | Paragon 28 | 51 | |
Peter Mariani | Axogen Inc | 60 | |
Alison Bauerlein | Sight Sciences | 43 | |
Roderick MacLeod | Nevro Corp | 57 |
Management Performance
Return On Equity | 0.11 | |||
Return On Asset | 0.0383 |
Siemens Healthineers Leadership Team
Elected by the shareholders, the Siemens Healthineers' board of directors comprises two types of representatives: Siemens Healthineers inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Siemens. The board's role is to monitor Siemens Healthineers' management team and ensure that shareholders' interests are well served. Siemens Healthineers' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Siemens Healthineers' outside directors are responsible for providing unbiased perspectives on the board's policies.
Andre Hartung, Head Imaging | ||
Christian Klaussner, Ex Fin | ||
Carsten Bertram, Head Therapies | ||
Bernhard Montag, President of the Management Board, CEO | ||
Christopher Toth, Head Varian | ||
Darleen Caron, Labor Officer | ||
Marc Koebernick, Head Relations | ||
Michel DVM, Pres Therapies | ||
Jochen Schmitz, CFO, Member of the Managing Board | ||
Elisabeth Staudinger, Member Board |
Siemens Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Siemens Healthineers a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.11 | |||
Return On Asset | 0.0383 | |||
Profit Margin | 0.09 % | |||
Operating Margin | 0.13 % | |||
Current Valuation | 59.39 B | |||
Shares Outstanding | 1.12 B | |||
Shares Owned By Insiders | 75.30 % | |||
Shares Owned By Institutions | 11.85 % | |||
Price To Earning | 29.13 X | |||
Price To Book | 3.20 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Siemens Pink Sheet
Siemens Healthineers financial ratios help investors to determine whether Siemens Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Siemens with respect to the benefits of owning Siemens Healthineers security.